Start Date
May 1, 2019
Primary Completion Date
May 1, 2022
Study Completion Date
May 1, 2023
Ascorbic Acid
25, 37.5, 56.25 or 75 grams/m2
Paclitaxel protein-bound
125mg/m2 over 30 minute IV infusions on days 1 and 8 repeated every 21 days
Cisplatin
25mg/m2 in 500 mL of NS over 60minute IV infusion on days 1 and 8 repeated every 21 days
Gemcitabine
1000mg/m2 in 500 mL over 30 minute IV infusion on days 1 and 8 repeated every 21 days
Piedmont Cancer Institute, PC, Fayetteville
Piedmont Cancer Institute, PC, Newnan
Piedmont Cancer Institute, PC, Atlanta
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
HonorHealth Research Institute, Scottsdale
University of California San Diego Moores Cancer Center, San Diego
Collaborators (2)
Cancer Research UK
OTHER
Stand Up To Cancer
OTHER
Lustgarten Foundation
OTHER
Destroy Pancreatic Cancer
OTHER
Translational Genomics Research Institute
OTHER
HonorHealth Research Institute
OTHER
Medical College of Wisconsin
OTHER